Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alfonso Iorio

Showing results (31-40 of 304) with videos related to

Pageof 31
Sort By:
Thrombosis Research|November 6, 2020
A comparison of methods for prediction of pharmacokinetics when switching to extended half-life products in hemophilia A patientsJacky K Yu, Alfonso Iorio, Andrea N Edginton
Research and Practice in Thrombosis and Haemostasis|July 12, 2019
Using pharmacokinetics for tailoring prophylaxis in people with hemophilia switching between clotting factor products: A scoping reviewJacky K Yu, Alfonso Iorio, Andrea N Edginton, et al.
The Cochrane Database of Systematic Reviews|August 6, 2010
Recombinant Factor VIIa concentrate versus plasma derived concentrates for the treatment of acute bleeding episodes in people with haemophilia and inhibitorsAlfonso Iorio, Davide Matino, Roberto D'Amico, et al.
Journal of Thrombosis and Haemostasis : JTH|July 1, 2024
Hemostatic management of von Willebrand disease during childbirth with a plasma-derived von Willebrand factor/factor VIII concentrateAlfonso Iorio, Paula James, Alice Ma, et al.
Journal of Clinical Epidemiology|October 8, 2019
Calculation of absolute risk for important outcomes in patients with and without a prognostic factor of interestFarid Foroutan, Alfonso Iorio, Lehana Thabane, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|May 20, 2020
Methodological considerations for investigating oral anticoagulation persistence in atrial fibrillationMiney Paquette, Lawrence Mbuagbaw, Alfonso Iorio, et al.
Vaccine|April 21, 2022
Extended reporting guidance for vaccine effectiveness studies for variants of concern for COVID-19Lori-Ann Linkins, Alfonso Iorio, Julian Little, et al.
The Cochrane Database of Systematic Reviews|January 22, 2010
Antiviral treatment for chronic hepatitis C in patients with human immunodeficiency virusAlfonso Iorio, Emanuela Marchesini, Tahany Awad, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|May 16, 2017
Thrombosis in Inherited Fibrinogen DisordersWolfgang Korte, Man-Chiu Poon, Alfonso Iorio, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 19, 2021
Converting factor and nonfactor usage into a single metric to facilitate benchmarking the resources consumed for haemophilia care across jurisdictions and over timeJeffrey S Stonebraker, Brian O'Mahony, Declan Noone, et al.
Pageof 31

Showing results (31-40 of 304) with videos related to

Sort By:
Pageof 31
Thrombosis Research|November 6, 2020
A comparison of methods for prediction of pharmacokinetics when switching to extended half-life products in hemophilia A patientsJacky K Yu, Alfonso Iorio, Andrea N Edginton
Research and Practice in Thrombosis and Haemostasis|July 12, 2019
Using pharmacokinetics for tailoring prophylaxis in people with hemophilia switching between clotting factor products: A scoping reviewJacky K Yu, Alfonso Iorio, Andrea N Edginton, et al.
The Cochrane Database of Systematic Reviews|August 6, 2010
Recombinant Factor VIIa concentrate versus plasma derived concentrates for the treatment of acute bleeding episodes in people with haemophilia and inhibitorsAlfonso Iorio, Davide Matino, Roberto D'Amico, et al.
Journal of Thrombosis and Haemostasis : JTH|July 1, 2024
Hemostatic management of von Willebrand disease during childbirth with a plasma-derived von Willebrand factor/factor VIII concentrateAlfonso Iorio, Paula James, Alice Ma, et al.
Journal of Clinical Epidemiology|October 8, 2019
Calculation of absolute risk for important outcomes in patients with and without a prognostic factor of interestFarid Foroutan, Alfonso Iorio, Lehana Thabane, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|May 20, 2020
Methodological considerations for investigating oral anticoagulation persistence in atrial fibrillationMiney Paquette, Lawrence Mbuagbaw, Alfonso Iorio, et al.
Vaccine|April 21, 2022
Extended reporting guidance for vaccine effectiveness studies for variants of concern for COVID-19Lori-Ann Linkins, Alfonso Iorio, Julian Little, et al.
The Cochrane Database of Systematic Reviews|January 22, 2010
Antiviral treatment for chronic hepatitis C in patients with human immunodeficiency virusAlfonso Iorio, Emanuela Marchesini, Tahany Awad, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|May 16, 2017
Thrombosis in Inherited Fibrinogen DisordersWolfgang Korte, Man-Chiu Poon, Alfonso Iorio, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 19, 2021
Converting factor and nonfactor usage into a single metric to facilitate benchmarking the resources consumed for haemophilia care across jurisdictions and over timeJeffrey S Stonebraker, Brian O'Mahony, Declan Noone, et al.
Pageof 31